skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

12 Total results for product and free and sample content found

Scrip

China Coronavirus Cases Up Sharply As Pharma Rushes To Aid

By Brian Yang 30 Jan 2020

China_Coronavirus_Cases_Up_Sharply

AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert endorsed its use, while other pharma companies from Bayer to Innovent are showering support as China battles its worst virus outbreak since the SARS epidemic 17 years ago.

Medtech Insight

QUOTED. 24 January 2020. Megan McSeveney.

30 Jan 2020

Quoted_24_January_2020

The FDA has readied plans for hastened emergency-use approvals of coronavirus test kits after an infected US citizen returned to Washington State from Wuhan province in China. See what the FDA’s Megan McSeveney said about it here.

Topic Drug approval Coronovirus FDA

Medtech Insight

CDC Shares Blueprint For Coronavirus Diagnostic With US State Laboratories

By Sue Darcey 30 Jan 2020

CDC_Shares_Blueprint_For_Coronavirus_Diagnostic

A new coronavirus test template developed by the US Centers for Disease Control and Prevention is being refined by the agency so it can be shared with domestic and international partners to help identify more cases of the virus.  In the meantime, state labs can use the posted assay for coronavirus on the CDC’s website for testing of residents within their jurisdiction and send results to the CDC.

Scrip

Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany

By Andrew McConaghie 30 Jan 2020

Atriva_Fast_Tracks_Antiviral_Candidate_1

The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.

Topic Coronovirus Vaccines

Scrip

Coronavirus: Can Companies Achieve Vaccine Ambition?

By Andrew McConaghie 30 Jan 2020

Coronavirus_Can_Companies_Achieve_Vaccines_Ambition

As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.

Topic Coronovirus Research Vaccines

Scrip

Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

By Andy Smith 30 Jan 2020

Stockwatch_Earnings_Season_Catches_An_Early_Cold

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

Scrip

Moderna Inovio Coronavirus Vaccine Candidates Fast-Tracked By International Coalition

By Andrew McConaghie 30 Jan 2020

Moderna_Inovio_Coronavirus_Vaccine_1

The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.

Topic Company Analysis Coronovirus Infectious Diseases Vaccines

Medtech Insight

Diagnostics Development For Coronavirus Begins As Second US Patient Tests Positive

By Sue Darcey 30 Jan 2020

Diagnostics_Development_For_Coronavirus_Begins

Bioresearchers at the Centers for Disease Control and Prevention are hoping that diagnostic platforms previously used to develop tests for outbreaks of other epidemic respiratory diseases, including SARS and MERS, can be built on to develop new diagnostics to detect more cases in the current coronavirus outbreak, US infectious disease authorities say. This comes as more patients are monitored around the US for the disease, and a Chicago woman returning from China tests positive.

Topic Drug approval Clinical Trials Coronovirus Policy and regulation

Medtech Insight

FDA ‘Stands Ready’ To Fight Coronavirus Via Emergency-Use Test Kits While WHO Mulls Virus Spread, Gets Out Guidance

By Sue Darcey 30 Jan 2020

FDA_Stands_Ready_To_Fight_Coronavirus

The US Food and Drug Administration (FDA) stands poised to proceed with hastened approvals for 2019-coronavirus (nCoV) diagnostics, treatments and vaccines, if a public health emergency is declared, after an infected US traveler who caught the disease in Wuhan, China returned from the province to Washington State. Spread of the disease has reached a crisis level in China, and the World Health Organization met on 22 and 23 January to consider what actions to take to contain the virus, while issuing an interim laboratory test guidance for use in diagnosing the disease.

Topic Drug approval Clinical Trials Coronovirus Policy and regulation

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: